Related Experiment Video
Updated: May 4, 2026

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
[Mycobacterium ulcerans disease (Buruli ulcer) in Gabon: 2005-2011]
L S Bayonne Manou1, F Portaels2, M Eddyani2
1Ministère de la Santé publique, BP 5258 Libreville, Gabon.
Buruli ulcer (BU) is endemic in Gabon, with most confirmed cases along the Ogooué River. Early diagnosis and treatment are crucial for managing this public health problem.
Area of Science:
- Neglected tropical diseases
- Mycobacterial infections
- Epidemiology
Context:
- Buruli ulcer (BU) cases have been documented in Gabon since the 1960s.
- A significant number of suspected BU cases were identified across Gabon between 2005 and 2011.
- Microbiological confirmation using Polymerase Chain Reaction (PCR) was employed to validate suspected cases.
Purpose:
- To determine the prevalence and geographical distribution of Buruli ulcer in Gabon.
- To characterize the clinical and epidemiological features of BU patients in Gabon.
- To assess the diagnostic accuracy of PCR in identifying Mycobacterium ulcerans and to evaluate treatment outcomes.
Summary:
- Out of 301 suspected cases, 120 (39.9%) tested positive for Mycobacterium ulcerans via PCR.
- Confirmed BU cases were predominantly found in the Moyen-Ogooué province, particularly along the Ogooué River.
- PCR-negative cases presented different demographic and lesion characteristics, highlighting the need for differential diagnosis. The cure rate for confirmed BU cases was 88% using WHO-recommended antibiotics.
Impact:
- This study confirms Buruli ulcer as an endemic public health issue in Gabon.
- Late patient presentation with extensive lesions necessitates enhanced awareness campaigns for earlier detection and treatment.
- Further research into the influence of HIV on Buruli ulcer in Gabon is warranted.
More Related Videos
08:34Identification of Virulence Markers of Mycobacterium abscessus for Intracellular Replication in Phagocytes
Published on: September 27, 2018
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Peptic Ulcer Disease III: Clinical Manifestations and Complications